Oncotelic Therapeutics, Inc. Equity Securities, FV-NI, Gain (Loss)
Oncotelic Therapeutics, Inc. (OTLC) reported Equity Securities, FV-NI, Gain (Loss) of $300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2026-08-13
- Oncotelic Therapeutics, Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2026-06-30 was $300.00K.
- Oncotelic Therapeutics, Inc. equity securities, fv-ni, gain (loss) for fiscal 2023 was $12.71K.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month | Equity Securities, FV-NI, Gain (Loss) 12 month |
|---|---|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-08-13 | $300.00K 10-Q · filed 2026-08-13 | |
| 2023-12-31 | $12.71K 10-K · filed 2024-04-12 |